Results 251 to 260 of about 192,765 (352)

Rare Thyroid Diseases Mimicking or Concealing Primitive Thyroid Neoplasms: A Call for a "Check and Double-Check" Clinical Mindset. [PDF]

Cureus
Duhamel F, Balti E, Waelput W, Raeymaeckers S, Verfaillie G, Luyten I, Andreescu CE.   +6 more
europepmc   +1 more source

Topographic expression of stem cell markers in differentiated thyroid follicular cell neoplasms

, 2012
H Elhassan, Nipin Bagla, I Roxanis, Leslie Lam, R Lam, J Moorhead, Salvador J. Díaz‐Cano   +6 more
openalex   +2 more sources

Hypervision Proton Surgery: The Future Direction of Proton Therapy

iNew Medicine, EarlyView.
ABSTRACT Proton beams provide unique physical advantages characterized by a low entrance dose, negligible exit dose, and a sharp Bragg peak, which enable superior sparing of normal tissues and support safe dose escalation for improved tumor control. However, conventional photon‐based fractionation remains widely used in proton therapy, where prolonged ...
Li Li, Shuanghu Yuan
wiley   +1 more source

Spatially Resolved Molecular Characterization of Noninvasive Follicular Thyroid Neoplasms with Papillary-like Nuclear Features (NIFTPs) Identifies a Distinct Proteomic Signature Associated with RAS-Mutant Lesions. [PDF]

Int J Mol Sci
Denti V, Greco A, Alviano AM, Capitoli G, Monza N, Smith A, Pilla D, Maggioni A, Ivanova M, Venetis K, Maffini F, Garancini M, Pincelli AI, Galimberti S, Magni F, Fusco N, L'Imperio V, Pagni F.   +17 more
europepmc   +1 more source

Study of non-invasive follicular thyroid neoplasm: A borderline entity

Rupali Bavikar, Ruchi Samir Randive, Anubhaw Verma, Madhuri Singh, Vidya Viswanathan, Arpana Dharwadkar   +5 more
openalex   +1 more source

THE VALIDITY OF IMMUNOCYTOCHEMISTRY IN DIFFERENTIATING BETWEEN BENIGN AND MALIGNANT THYROID NEOPLASMS PREOPERATIVELY USING FNAC

, 2017
Karthika Kundil Veetil, Rajeevan K. Nileshwar   +1 more
openalex   +1 more source

Inflammatory bowel disease and metabolic reprogramming: From pathological mechanisms to targeted interventions

Interdisciplinary Medicine, EarlyView.
This review explores the role of metabolic reprogramming in inflammatory bowel disease (IBD) by focusing on immune and epithelial cell metabolism, microbial metabolites, and their impact on inflammation. It discusses emerging metabolic therapies and emphasizes the importance of personalized microbiota‐targeted approaches to improve clinical outcomes in
Zemin Tian, Yinde Huang, Ying Wang, Chenyu Zhao, Zhaokai Zhou, Hua Yang, Yuan Qiu   +6 more
wiley   +1 more source

Chinese pan‐cancer patient genomic characteristics: A comprehensive analysis based on the National Cancer Center–Clinical Diagnostics Knowledgebase real‐world clinical sequencing cohort

Interdisciplinary Medicine, EarlyView.
We assembled National Cancer Center–Clinical Diagnostics Knowledgebase, a clinical genomic knowledgebase of 6935 tumors with matched normal samples, revealing key somatic alterations and actionable variants (70.2% of the cohort). Enrichment of certain different gene mutations was observed between Chinese and American populations, along with a strong ...
Hongrui Li, Shun Wang, Guowei Zhao, Jiangtao Li, Xin Li, Bingning Wang, Yi Zhang, Mengfei Yao, Lei Guo, Jianming Ying, Wenbin Li   +10 more
wiley   +1 more source

The molecular pathology of thyroid neoplasms

, 2014
JB Thapa
openalex   +2 more sources

Lymph‐based liquid biopsy: Current progress and future potential

Interdisciplinary Medicine, EarlyView.
Recent evidence under the revised Starling principle indicates that lymph‐based liquid biopsies may offer superior diagnostic performance over blood‐based counterparts in certain clinical scenarios, such as early‐stage solid tumor detection. Currently, various biomarkers within the lymphatic system show significant diagnostic potential for a range of ...
Dongdong Liu, Leheng Cheng, Xiaolin Hu, Sergio Bernardini, Hong Zhang, Ling Zhu, Yang Luo   +6 more
wiley   +1 more source